US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist
  • 7.640
  • +0.180+2.41%
Trading Nov 27 11:54 ET
360.72MMarket Cap-4523P/E (TTM)

Silence Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Silence Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: GBP

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.050M--
--2024/Q4-- / 3.718M--
--2024/Q31.142M / 3.000M--
--2024/Q2598.000K / 9.850M--
--2024/Q112.406M / 3.550M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.050M--
--2024/Q4-- / 3.718M--
--2024/Q31.142M / 3.000M--
--2024/Q2598.000K / 9.850M--
--2024/Q112.406M / 3.550M--

Unlock Free Earnings Estimates

Silence Therapeutics Earnings Reports

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14 09:26 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 15 09:07 ET

  • 6-K: Report of foreign private issuer (related to financial reporting)

    May 16 14:26 ET

  • Silence Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 15 07:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 15, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data